FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2273102460> ?p ?o ?g. }

• W2273102460 abstract "Everolimus -eluting stent (EES) is common used in patients undergoing percutaneous coronary interventions (PCI). Our purpose is to evaluate long-term clinical outcomes of everolimus -eluting stent (EES) versus paclitaxel-eluting stent (PES) in patients undergoing percutaneous coronaryinterventions (PCI) in randomized controlled trials (RCTs). We searched Medline, EMBASE, Cochrane Library, CNKI, VIP and relevant websites ( https://scholar-google-com.ezproxy.lib.usf.edu/ ) for articles to compare outcomes between everolimus-eluting stent and paclitaxel-eluting stent without language or date restriction. RCTs that compared the use of everolimus -eluting stent and paclitaxel-eluting stent in PCI were included. Variables relating to patient, study characteristics, and clinical endpoints were extracted. Meta-analysis was performed using RevMan 5.2 software. We identified 6 published studies (from three randomized trials) more on everolimus-eluting stent (n = 3352) than paclitaxel-eluting (n = 1639), with follow-up duration ranging from 3, 4 and 5 years. Three-year outcomes of everolimus-eluting stent compared to paclitaxel-eluting were as following: the everolimus-eluting stent significantly reduced all-cause death (relative risk [RR]:0.63; 95 % confidence interval [CI]: 0.46. to 0.82), MACE (RR: 0.56; 95 % CI: 0.41 to 0.77), MI (RR: 0.64; 95 % CI: 0.48 to 0.86), TLR (RR: 0.72; 95 % CI: 0.59 to 0.88), ID-TLR (RR: 0.74; 95 % CI: 0.59 to 0.92) and ST (RR: 0.54; 95 % CI: 0.32 to 0.90). There was no difference in TVR between the everolimus-eluting and paclitaxel-eluting (RR: 0.76; 95 % CI: 0.58 to 1.10); Four-year outcomes of everolimus-eluting compared to paclitaxel-eluting: the everolimus-eluting significantly reduced MACE (RR: 0.44; 95 % CI: 0.18 to 0.98) and ID-TLR (RR: 0.47; 95 % CI: 0.23 to 0.97). There was no difference in MI (RR: 0.48; 95 % CI: 0.16 to 1.46), TLR (RR: 0.46; 95 % CI: 0.20 to1.04) and ST ((RR: 0.34; 95 % CI: 0.05 to 2.39). Five-year outcomes of everolimus-eluting stent compared to paclitaxel-eluting: There was no difference in ID-TLR (RR: 0.67; 95 % CI: 0.45 to 1.02) and ST (RR: 0.71; 95 % CI: 0.28 to1.80). In the present meta-analysis, everolimus-eluting appeared to be safe and clinically effective in patients undergoing PCI in comparison to PES in 3-year clinical outcomes; there was similar no difference in reduction of ST between EES and PES in long-term(≥4 years) clinical follow-ups. Everolimus-eluting is more safety than paclitaxel-eluting in long-term clinical follow-ups, whether these effects can be applied to different patient subgroups warrants further investigation." @default.
• W2273102460 created "2016-06-24" @default.
• W2273102460 creator A5015308986 @default.
• W2273102460 creator A5025167498 @default.
• W2273102460 creator A5032091275 @default.
• W2273102460 creator A5050716712 @default.
• W2273102460 creator A5065836602 @default.
• W2273102460 creator A5091165819 @default.
• W2273102460 date "2016-02-09" @default.
• W2273102460 modified "2023-10-16" @default.
• W2273102460 title "Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis" @default.
• W2273102460 cites W117366895 @default.
• W2273102460 cites W1480729244 @default.
• W2273102460 cites W149951570 @default.
• W2273102460 cites W1590976202 @default.
• W2273102460 cites W1598602811 @default.
• W2273102460 cites W1718290785 @default.
• W2273102460 cites W1737944821 @default.
• W2273102460 cites W1838361749 @default.
• W2273102460 cites W1965848598 @default.
• W2273102460 cites W1966887813 @default.
• W2273102460 cites W1971450744 @default.
• W2273102460 cites W1972908928 @default.
• W2273102460 cites W1980671998 @default.
• W2273102460 cites W1987715200 @default.
• W2273102460 cites W1988905390 @default.
• W2273102460 cites W1989556574 @default.
• W2273102460 cites W1998827401 @default.
• W2273102460 cites W2005501262 @default.
• W2273102460 cites W2016738189 @default.
• W2273102460 cites W2029986831 @default.
• W2273102460 cites W2039085311 @default.
• W2273102460 cites W2052702450 @default.
• W2273102460 cites W2054931962 @default.
• W2273102460 cites W2059289792 @default.
• W2273102460 cites W2070818544 @default.
• W2273102460 cites W2073266518 @default.
• W2273102460 cites W2078073700 @default.
• W2273102460 cites W2085450628 @default.
• W2273102460 cites W2087641863 @default.
• W2273102460 cites W2098844160 @default.
• W2273102460 cites W2102010919 @default.
• W2273102460 cites W2107234115 @default.
• W2273102460 cites W2116362164 @default.
• W2273102460 cites W2119785324 @default.
• W2273102460 cites W2120754408 @default.
• W2273102460 cites W2126015863 @default.
• W2273102460 cites W2131308249 @default.
• W2273102460 cites W2141469367 @default.
• W2273102460 cites W2143318754 @default.
• W2273102460 cites W2146674516 @default.
• W2273102460 cites W2146743728 @default.
• W2273102460 cites W2147556813 @default.
• W2273102460 cites W2150086052 @default.
• W2273102460 cites W2161895979 @default.
• W2273102460 cites W2165162953 @default.
• W2273102460 cites W2329013503 @default.
• W2273102460 cites W4248566459 @default.
• W2273102460 cites W4249875266 @default.
• W2273102460 cites W5864417 @default.
• W2273102460 cites W81997084 @default.
• W2273102460 cites W90678752 @default.
• W2273102460 cites W99264662 @default.
• W2273102460 doi "https://doi.org/10.1186/s12872-016-0206-6" @default.
• W2273102460 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4748592" @default.
• W2273102460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26860585" @default.
• W2273102460 hasPublicationYear "2016" @default.
• W2273102460 type Work @default.
• W2273102460 sameAs 2273102460 @default.
• W2273102460 citedByCount "7" @default.
• W2273102460 countsByYear W22731024602017 @default.
• W2273102460 countsByYear W22731024602018 @default.
• W2273102460 countsByYear W22731024602019 @default.
• W2273102460 countsByYear W22731024602020 @default.
• W2273102460 countsByYear W22731024602023 @default.
• W2273102460 crossrefType "journal-article" @default.
• W2273102460 hasAuthorship W2273102460A5015308986 @default.
• W2273102460 hasAuthorship W2273102460A5025167498 @default.
• W2273102460 hasAuthorship W2273102460A5032091275 @default.
• W2273102460 hasAuthorship W2273102460A5050716712 @default.
• W2273102460 hasAuthorship W2273102460A5065836602 @default.
• W2273102460 hasAuthorship W2273102460A5091165819 @default.
• W2273102460 hasBestOaLocation W22731024601 @default.
• W2273102460 hasConcept C126322002 @default.
• W2273102460 hasConcept C141071460 @default.
• W2273102460 hasConcept C168563851 @default.
• W2273102460 hasConcept C203092338 @default.
• W2273102460 hasConcept C2776478404 @default.
• W2273102460 hasConcept C2778583881 @default.
• W2273102460 hasConcept C2779699572 @default.
• W2273102460 hasConcept C2780400711 @default.
• W2273102460 hasConcept C2780739214 @default.
• W2273102460 hasConcept C44249647 @default.
• W2273102460 hasConcept C45393284 @default.
• W2273102460 hasConcept C500558357 @default.
• W2273102460 hasConcept C71924100 @default.
• W2273102460 hasConcept C82789193 @default.
• W2273102460 hasConceptScore W2273102460C126322002 @default.
• W2273102460 hasConceptScore W2273102460C141071460 @default.
• W2273102460 hasConceptScore W2273102460C168563851 @default.

• next